NCT05179525View on ClinicalTrials.gov

Comparative Bioavailability of Risperidone.

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

September 17, 2021

Study Completion Date

September 17, 2021

Conditions
Schizophrenia
Interventions
DRUG

Risperidone ISM® 100 mg

100 mg of risperidone ISM® administered every 4 weeks

DRUG

Risperdal 4mg Tablet

4 mg oral risperidone once daily for 7 days

Trial Locations (4)

20877

CBH Health, LLC, Gaithersburg

75115

Rajinder Shiwach, DeSoto

92845

Collaborative NeuroScience Research, LLC, Garden Grove

08009

Hassman Research Institute, Berlin

All Listed Sponsors
lead

Rovi Pharmaceuticals Laboratories

INDUSTRY

NCT05179525 - Comparative Bioavailability of Risperidone. | Biotech Hunter | Biotech Hunter